Repeated radioembolization in advanced liver cancer.

ABSTRACT:

Background

To evaluate safety and clinical outcome of repeated transarterial ⁹⁰Y (yttrium) radioembolization (TARE) in primary and metastatic liver cancer.

Methods

Between 2009 and 2018, n=288 patients underwent TARE for treatment of malignant liver disease in a tertiary care hospital. This retrospective single center study analyzed the safety and outcome of patients (n=11/288) undergoing repeated resin microsphere TARE. Included patients suffered from hepatocellular carcinoma (n=3), colorectal cancer (n=2), breast cancer (n=2), intrahepatic cholangiocarcinoma (n=3), and neuroendocrine carcinoma (n=1). All patients had shown either partial response (n=9) or stable disease (n=2) after first TARE. Lab parameters, response assessed by the Response Evaluation Criteria

SUBMITTER: Masthoff M 

PROVIDER: S-EPMC7575953 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature